INNOCARE PHARMA LTD
Research INNOCARE PHARMA LTD (33C) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- Ticker33C
- ExchangeF
- CurrencyEUR
- Financial periodFY2025
- RevenueEUR 2.37B
- Revenue growth135.3%
- Net incomeEUR 642.47M
- Free cash flowEUR 13.77M
- Gross margin92.0%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 2.37B | EUR 642.47M | EUR 13.77M | 92.0% | 0.38 | EUR 7.05B | EUR 1.29B | EUR 7.73B |
| FY2024 | EUR 1.01B | -EUR 440.63M | -EUR 443.78M | 86.3% | -0.26 | EUR 6.22B | EUR 1.27B | EUR 6.73B |
| FY2023 | EUR 738.54M | -EUR 631.26M | -EUR 926.00M | 82.6% | -0.37 | EUR 8.22B | EUR 1.35B | EUR 7.15B |
| FY2022 | EUR 625.40M | -EUR 886.59M | -EUR 935.88M | 77.1% | -0.6 | EUR 8.70B | EUR 1.25B | EUR 7.60B |
| FY2021 | EUR 1.04B | -EUR 64.55M | -EUR 4.15M | 93.7% | n/a | EUR 5.93B | EUR 1.27B | EUR 5.60B |